Protocol Ledger

NCT04498273 · Phase III · TERMINATED

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Interventional Phase III clinical trial protocol NCT04498273 sponsored by Frank C Sciurba in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-09-07 Enrollment: 657 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04498273
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)657 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04498273
Protocol FieldVerified Registry Value
NCT IdentifierNCT04498273
Consolidated Lead SponsorFrank C Sciurba
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase III
Overall Recruitment StatusTERMINATED
Registered Enrollment657 participants (ACTUAL)
Registered Start Date2020-09-07
WhyStopped ClassificationUnspecified

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04498273
Hospital Research SiteLocationSite Profile
USC Norris Comprehensive Cancer Center and Keck MedicineLos Angeles, CAOpen Hospital Dossier ->
Stanford Health Care and Stanford Cancer InstituteStanford, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI